Cargando…
The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
Esophageal carcinoma (EC) is always diagnosed at advanced stage and its the mortality rate remains high. The patients usually miss the best opportunity for treatment because of non-specific symptoms and the survival rates are low. N6-methyladenosine (m6A) the predominant modification in eukaryotic m...
Autores principales: | He, Cheng, Teng, Xiao, Wang, Luming, Ni, Miaoqi, Zhu, Linhai, Liu, Jiacong, Lv, Wang, Hu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520198/ https://www.ncbi.nlm.nih.gov/pubmed/37598390 http://dx.doi.org/10.1007/s11033-023-08575-2 |
Ejemplares similares
-
Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma
por: Wu, Yaohai, et al.
Publicado: (2023) -
The roles of RNA N(6)-methyladenosine in esophageal cancer
por: Teng, Chuan, et al.
Publicado: (2022) -
Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021) -
Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022) -
Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer’s disease
por: Ni, Pengyun, et al.
Publicado: (2023)